Ozempic Lawsuits: Gastroparesis Stomach Paralysis Injury Claims

Have Questions?

---

FILL OUT THE FORM BELOW
TO REQUEST YOUR CASE REVIEW

Select Your State... Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District Of Columbia Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming

REVIEW MY CASE

By submitting I consent to be contacted to discuss my legal options by Lawsuit Legal and/or our legal partners and agree to receive calls, sms, emails. We may rely on co-counsel. I agree to the Terms of Use and Privacy Policy.

Latest Ozempic Lawsuit Updates

Our attorneys are investigating injury claims from patients hospitalized for gastroparesis after taking Ozempic or other any other RD1 inhibitor drugs.

For claimant eligibility, a doctor diagnosis of gastroparesis, gastric stasis, gastric paralysis, or gastric obstruction is required.

You must have been hospitalized, received inpatient care, or required visits to the ER as a result of use.

Fill out the form to check eligibility and determine if you qualify to file a lawsuit.

Ozempic gastroparesis lawsuits allege complications after multiple patients came forward experiencing severe gastroparesis.

These paralyzed stomachs can result in severe abdominal pain and require significant medical treatment.

The following patient symptoms are being reported:

• Gastroparesis / Stomach Paralysis
• Persistent Vomiting
• Persistent Nausea
• Persistent Diarrhea
• Hospitalization
• Sudden Vision Loss
• Bowel Obstruction
• Esophageal Injury w/ Surgical Intervention

November 1, 2024 – New Cases Added to MDL

Our ozempic lawyers will continue to update the latest updates on the GLP-1 agonist litigation.

The parent company of Ozempic has rejected claims that the drug is unsafe.

According to our data, we estimate that as many as 10,000 plaintiffs will ultimately file, and the number is expected to rise significantly with time.

 

UPDATE: A new MDL formed to handle Ozempic gastroparesis claims (MDL #3094 GLP-1 receptor agonist drugs)

 

Who Qualifies to File an Ozempic Lawsuit:

Our Ozempic lawsuit attorneys are reviewing patient complication claims. Complications patients have named in lawsuits include the following adverse fact patterns.

• Gastroparesis / Stomach Paralysis: A condition in which the stomach cannot move food as it should to the small intestines for excretion. No blockage exists, normal digestion is disrupted and it can be life-threatening in severe instances.
• Persistent Vomiting: Constant vomiting can lead to severe dehydration and esophageal damage.
• Persistent Nausea: Painful nausea can disrupt the quality of life and prevent victims from being able to work or perform day-to-day activities. It can also be a symptom of Bezoars, indicating a solid mass of undigested food has hardened in the stomach, which can be life-threatening.
• Persistent Diarrhea: Constant diarrhea can cause severe dehydration and require hospitalization to treat.

 

The medications Mounjaro and Wegovy to cases of severe gastrointestinal problems along with persistent vomiting, nausea, and diarrhea.

Removing implanted mesh can be very difficult as tissue grows around the material in the abdominal wall after it has been placed. This can lead to treatment requiring multiple revision surgeries.

Surgical mesh has been used to treat pelvic organ prolapse and stress urinary incontinence in the U.S. since 1996. Mesh, however, first became a focus of personal injury litigation in October 2008 and again in February 2009, when the U.S. Food and Drug Administration issued Public Health Notifications regarding the use of mesh products in treating pelvic organ prolapse and stress urinary incontinence. Device manufacturers Atrium, C.R. Bard, Bard Davol, and Ethicon have been named with open and pending lawsuit cases.

Ozempic Lawsuit Updates:

The petition to consolidate Ozempic lawsuits into multi-district litigation was filed and confirmed. The gastroparesis claims have been consolidated into GLP-1 MDL 3094, Centralized in Pennsylvania. At the time of this writing, there are 66 pending cases against the drugmakers included in the litigation. The semaglutide medications saw a surge in use when doctors began prescribing them and people began taking them off-label for weight loss.

The ongoing investigation is looking into the following claims against the manufacturers:

• Defective Product Design
• Defective Product Manufacturing
• Improper Labeling & Failure to Warn Patients for Risk of Severe Gastrointestinal Problems
• Medical Malpractice Committed by Plaintiffs' Doctors who Prescribed the Drug Off-label for Weight Loss

Personal injury lawsuits for gastroparesis are the latest legal development associated with the GLP-1 agonist drugs Ozempic, Rybelsus, Saxenda, and Wegovy.

If you or a loved one have experienced symptoms and were hospitalized after using one of these drugs, our attorneys are here to help.

Filing Gastroparesis Ozempic Lawsuits

If you took any of the semaglutide drugs mentioned and were diagnosed with gastroparesis from a doctor, you may be eligible to file a personal injury lawsuit seeking compensation. Lawyers are investigating patient claims involving severe gastrointestinal problems and are seeking compensation for the adverse impact suffered.

Potential Compensation for Damages May Include:

• Costs of Medical Bills
• Lost Earnings, Past & Future
• Loss of Quality of Life
• Pain & Suffering

People who were forced to go to the emergency room and suffered severe stomach problems should have been adequately warned of the potential risks. Filing a lawsuit against the manufacturers for the personal injuries suffered provides patients with a possible path to compensation. A successful jury verdict would hold these companies responsible for their alleged failure to warn patients of the potential for severe stomach paralysis and its complications.

Who Qualifies for a Claim

If you feel you have a potential injury claim and would like to join the MDL, consider the following criteria to qualify claimants. Potential claimants who fit the following criteria may be eligible to file a claim:

• Experience gastroparesis (stomach paralysis), intestinal blockage, or persistent vomiting with either an Emergency Room visit or hospitalization due to the above injuries.
• Have used: Ozempic, Wegovy, Mounjaro, Rybelsus, Saxenda, Trulicity or Zepbound.
• Are no longer taking the medication

 

Alleged: Ozempic Failed to Warn Patients

Attorneys with Morgan & Morgan allege a lack of adequate safety warnings from drug manufacturers.

The lawsuit alleges Novo Nordisk and Eli Lilly and Co., manufacturers of the weight loss drugs Ozempic and Mounjaro, failed to provide adequate safety warnings about the risk of severe gastroparesis. Patients who suffered paralyzed stomachs after taking the medications may qualify to file an individual lawsuit of their own to join the mass tort litigation.